Physician

Darko Vucicevic, M.D.

According to 2025 Medicare claims, Darko Vucicevic, M.D. (NPI: 1134396591) practices advanced heart failure and transplant cardiology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1235107566; TIN: 954373071) and primary practice location at 90095-0001. Vucicevic is affiliated with the RWJBH Accountable Care, LLC (ACO ID: A1247) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Vucicevic's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 476 traditional Medicare patients, billed 2,409 HCPCS/CPT codes, and received $206,246 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 4,764 prescription claims across 496 beneficiaries totaling $5,680,161 in drug costs, led by Vyndamax (Tafamidis). DME data shows 1,402 claims. Open Payments data shows 4 records totaling $316. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,984 to $206,246. Similarly, Part D prescription costs have moved sharply higher in recent years, from $14,584 to $5,680,161. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	54	82	$3,984
2016	49	66	$2,961
2017	N/R	N/R	N/R
2018	183	955	$82,565
2019	170	798	$63,754
2020	228	779	$73,477
2021	318	1,160	$118,944
2022	367	1,401	$146,112
2023	427	1,595	$157,293
2024	476	2,409	$206,246

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	38	212	$14,584
2016	27	157	$7,226
2017	N/R	17	$417
2018	34	198	$39,642
2019	54	276	$370,328
2020	223	1,191	$570,547
2021	316	3,381	$521,491
2022	364	3,834	$1,444,196
2023	440	4,194	$2,914,939
2024	496	4,764	$5,680,161

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	88	$4,976
2019	N/R	84	$3,837
2020	127	443	$15,730
2021	275	1,525	$53,908
2022	258	1,679	$48,383
2023	238	1,337	$33,593
2024	254	1,402	$27,186

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	54	54	$157
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	265	514	$119
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	98	403	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	182	268	$80
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	308	599	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	131	5,190	$3,932,738
Camzyos	Mavacamten	44	1,270	$353,374
Vyndaqel	Tafamidis Meglumine	14	420	$276,510
Entresto	Sacubitril/Valsartan	262	13,380	$273,530
Farxiga	Dapagliflozin Propanediol	231	11,820	$215,567

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	75	327	$5,510
J7507	Tacrolimus, immediate release, oral, 1 mg	N	64	336	$5,160
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	66	348	$4,251
J7517	Mycophenolate mofetil, oral, 250 mg	N	32	169	$3,270
J7520	Sirolimus, oral, 1 mg	N	17	66	$2,194

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$316	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Darko Vucicevic, M.D.?

Tedicare shows public-source Medicare data for Darko Vucicevic, M.D. (NPI 1134396591), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Darko Vucicevic, M.D. have ACO affiliation data?

Darko Vucicevic, M.D. is shown with ACO affiliation data for RWJBH Accountable Care, LLC (MSSP, ACO ID A1247) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Darko Vucicevic, M.D.?

Darko Vucicevic, M.D. is linked to THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (billing NPI 1235107566) in the available physician profile data.

Does Darko Vucicevic, M.D. have Open Payments data?

Darko Vucicevic, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.